Abstract: The epidermal growth factor receptor variant III (EGFRvIII) also known as the most common mutant form of EGFR is a tumor-specific mutation, hasn’t yet been detected in normal tissues. It is regarded as a tumor-specific gene and offers a new way for targeted therapy of ovarian cancer.

Key words: epidermal growth factor receptor, epidermal growth factor receptor variant III, ovarian cancer, targeted treatment